Stay updated on EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Sign up to get notified when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.

Latest updates to the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page
- Check5 days agoChange DetectedUpdated revision from v3.3.3 to v3.3.4 on the page; this is a minor UI/version change that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a Locations section listing study sites by state and updated the page revision to v3.3.3.SummaryDifference2%

- Check57 days agoChange DetectedAn updated note in the Publications section clarifies that items are auto-filled from PubMed and may not all pertain to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe government funding lapse notice warning that information may not be up to date and transactions may not be processed has been removed from the page. This banner was an operational notice and did not affect the core study details.SummaryDifference0.4%

- Check78 days agoChange DetectedThe update appears to be a minor metadata refresh (last update date 2025-06-06) with no changes to study design, eligibility criteria, primary endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check107 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

Stay in the know with updates to EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.